Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Hypertension in Primary Aldosteronism Is Initiated by Salt-Induced Increases in Vascular Resistance With Reductions in Cardiac Output

TW. Kurtz, RC. Morris, M. Pravenec, HL. Lujan, SE. DiCarlo

. 2023 ; 80 (5) : 1077-1091. [pub] 20230307

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc23011545

BACKGROUND: Few studies have investigated the hemodynamic mechanism whereby primary aldosteronism causes hypertension. The traditional view holds that hyperaldosteronism initiates hypertension by amplifying salt-dependent increases in cardiac output (CO) by promoting increases in sodium retention and blood volume. Systemic vascular resistance (SVR) is said to increase only as a secondary consequence of the increased CO and blood pressure. However, mounting evidence indicates that aldosterone can influence multiple pathways regulating vascular tone. We investigated the primary hemodynamic mechanism whereby hyperaldosteronism promotes salt sensitivity and initiation of salt-dependent hypertension. METHODS: In unilaterally nephrectomized male Sprague-Dawley rats given infusions of aldosterone or vehicle, we used chronically implanted arterial pressure probes and Doppler ultrasonic flow probes to continuously monitor changes in mean arterial pressure, CO, and SVR 24 hours/day, 7 days/week in response to increases in salt intake. RESULTS: In vehicle-treated control rats, switching from a low-salt diet to a high-salt diet initiated modest increases in mean arterial pressure by increasing SVR while simultaneously decreasing heart rate and CO. In aldosterone-treated rats compared with control rats, switching from a low-salt diet to a high-salt diet initiated significantly greater increases in mean arterial pressure and SVR and significantly greater decreases in heart rate and CO. CONCLUSIONS: Aldosterone promoted salt sensitivity and initiation of salt-dependent hypertension by amplifying salt-induced increases in SVR while decreasing CO. Increases in CO are not required for the initiation or maintenance of hypertension. These findings challenge the traditional view of the hemodynamic mechanisms that cause hypertension in primary aldosteronism.

000      
00000naa a2200000 a 4500
001      
bmc23011545
003      
CZ-PrNML
005      
20230801133127.0
007      
ta
008      
230718s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1161/HYPERTENSIONAHA.123.20953 $2 doi
035    __
$a (PubMed)37043613
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kurtz, Theodore W $u Department of Laboratory Medicine (T.W.K.), University of California, San Francisco $1 https://orcid.org/0000000304365456
245    10
$a Hypertension in Primary Aldosteronism Is Initiated by Salt-Induced Increases in Vascular Resistance With Reductions in Cardiac Output / $c TW. Kurtz, RC. Morris, M. Pravenec, HL. Lujan, SE. DiCarlo
520    9_
$a BACKGROUND: Few studies have investigated the hemodynamic mechanism whereby primary aldosteronism causes hypertension. The traditional view holds that hyperaldosteronism initiates hypertension by amplifying salt-dependent increases in cardiac output (CO) by promoting increases in sodium retention and blood volume. Systemic vascular resistance (SVR) is said to increase only as a secondary consequence of the increased CO and blood pressure. However, mounting evidence indicates that aldosterone can influence multiple pathways regulating vascular tone. We investigated the primary hemodynamic mechanism whereby hyperaldosteronism promotes salt sensitivity and initiation of salt-dependent hypertension. METHODS: In unilaterally nephrectomized male Sprague-Dawley rats given infusions of aldosterone or vehicle, we used chronically implanted arterial pressure probes and Doppler ultrasonic flow probes to continuously monitor changes in mean arterial pressure, CO, and SVR 24 hours/day, 7 days/week in response to increases in salt intake. RESULTS: In vehicle-treated control rats, switching from a low-salt diet to a high-salt diet initiated modest increases in mean arterial pressure by increasing SVR while simultaneously decreasing heart rate and CO. In aldosterone-treated rats compared with control rats, switching from a low-salt diet to a high-salt diet initiated significantly greater increases in mean arterial pressure and SVR and significantly greater decreases in heart rate and CO. CONCLUSIONS: Aldosterone promoted salt sensitivity and initiation of salt-dependent hypertension by amplifying salt-induced increases in SVR while decreasing CO. Increases in CO are not required for the initiation or maintenance of hypertension. These findings challenge the traditional view of the hemodynamic mechanisms that cause hypertension in primary aldosteronism.
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a zvířata $7 D000818
650    _2
$a aldosteron $7 D000450
650    _2
$a kuchyňská sůl $x škodlivé účinky $7 D017673
650    _2
$a potkani Sprague-Dawley $7 D017207
650    12
$a hypertenze $7 D006973
650    _2
$a hemodynamika $7 D006439
650    _2
$a krevní tlak $7 D001794
650    _2
$a minutový srdeční výdej $7 D002302
650    _2
$a cévní rezistence $7 D014655
650    12
$a hyperaldosteronismus $x komplikace $7 D006929
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Morris, R Curtis $u Department of Medicine (R.C.M.), University of California, San Francisco
700    1_
$a Pravenec, Michal $u Institute of Physiology of the Czech Academy of Sciences, Prague (M.P.) $1 https://orcid.org/0000000191975871 $7 nlk20030127611
700    1_
$a Lujan, Heidi L $u Department of Physiology, College of Osteopathic Medicine, Michigan State University, East Lansing (H.L.L., S.E.D.)
700    1_
$a DiCarlo, Stephen E $u Department of Physiology, College of Osteopathic Medicine, Michigan State University, East Lansing (H.L.L., S.E.D.)
773    0_
$w MED00002089 $t Hypertension (Dallas, Tex. : 1979) $x 1524-4563 $g Roč. 80, č. 5 (2023), s. 1077-1091
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37043613 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230718 $b ABA008
991    __
$a 20230801133123 $b ABA008
999    __
$a ok $b bmc $g 1963768 $s 1197810
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 80 $c 5 $d 1077-1091 $e 20230307 $i 1524-4563 $m Hypertension $n Hypertension $x MED00002089
LZP    __
$a Pubmed-20230718

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...